Bioverativ launches late-stage development of BIVV009 in rare blood disease [Seeking Alpha]
BIOVERATIV INC COMMON (BIVV)
Last bioverativ inc common earnings: 2/13 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bioverativ.com/phoenix.zhtml?c=254463&p=irol-irhome_pf
Company Research
Source: Seeking Alpha
Bioverativ launches late-stage development of BIVV009 in rare blood diseaseDosing is underway in a Phase 3 program assessing Bioverativ's (NASDAQ:BIVV) BIVV009 in patients withcold agglutinin disease (CAgD); a rare autoimmune disorder in which the body's immune system destroys red blood cells.Two parallel studies,CARDINAL andCADENZA, will be conducted. There are approved therapies for the disease. The estimated primary completion dates are June 2019 and December 2019, respectively.Breakthrough Therapy- and Orphan Drug-tagged BIVV0090 is a monoclonal antibody designed to target the root cause of CAgD by blocking the C1 complex in the complement pathway. Thecomplement system is a part of the immune system that enhances (complements) the ability of antibodies to remove pathogens and cellular debris.Click to subscribe to real-time analytics on BIVVNow read:Your Daily Pharma Scoop: Aimmune Data, Onconova Shares Get A Boost, G1 Therapeutics' Positive Data »
Show less
Read more
Impact Snapshot
Event Time:
BIVV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIVV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIVV alerts
High impacting BIOVERATIV INC COMMON news events
Weekly update
A roundup of the hottest topics